Gregroy Hardee;Henrik Orum;Marie Wickstrom Lindholm;Henrik Hansen;Ellen Marie Straarup
发明人:
Gregroy Hardee,Ellen Marie Straarup,Marie Wickstrom Lindholm,Henrik Orum,Henrik Hansen
申请号：
US13503189
公开号：
US20120322851A1
申请日:
2010.10.20
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The invention provides for LNA oligomers, for the treatment of a metabolic or liver disorder, wherein the LNA oligomer is administered orally in a unit dose of less than 50 mgs/kg, wherein the LNA oligomer is administered in the presence of a penetration (permeation) enhancer.
